Profound Medical (TSX:PRN) Net Change in Cash : C$-27.35 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Profound Medical Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Profound Medical's Net Change in Cash for the three months ended in Dec. 2023 was C$-9.94 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was C$-27.35 Mil.

Profound Medical Net Change in Cash Historical Data

The historical data trend for Profound Medical's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Profound Medical Net Change in Cash Chart

Profound Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-10.13

88.53

-21.46

-28.03

-27.24

Profound Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Change in Cash	Get a 7-Day Free Trial															0.42	-4.83	-4.93	-7.65	-9.94

Profound Medical Net Change in Cash Calculation

Profound Medical's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-29.914	+	0	+	1.964	+	0.71
	=	-27.24

Profound Medical's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -9.414 + 0 + -0.659 + 0.129

= -9.94

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-27.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Profound Medical Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Profound Medical's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Profound Medical (TSX:PRN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Profound Medical Corp (TSX:PRN) » Definitions » Net Change in Cash

Comparable Companies

TSX:HTL TSX:QIPT TSX:VMD TSXV:PINK TSXV:TLT TSXV:ASG TSXV:VPT XCNQ:BLO TSXV:NGMD TSXV:SGMD ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA

Traded in Other Exchanges

PROF:USA

Address

2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5

Website

https://www.profoundmedical.com

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Profound Medical (TSX:PRN) Headlines